Nykode Therapeutics - Grant of share options
Nykode Therapeutics ASA (NYKD) · publisert 2024-07-01 18:20 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Michael Engsig | – | other | 494 749 | 0 NOK | 2024-07-01 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Harald Gurvin | – | other | 183 304 | 0 NOK | 2024-07-01 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Agnete B. Fredriksen | – | other | 177 515 | 0 NOK | 2024-07-01 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Klaus Edvardsen | – | other | 212 927 | 0 NOK | 2024-07-01 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Louise Stubbe | – | other | 163 965 | 0 NOK | 2024-07-01 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
Vedlegg
- Attachment 240701.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, July 1, 2024 - A total of 3,159,019 share options have been granted to employees of Nykode Therapeutics ASA under the company’s share option scheme, of which 1,232,460 share options have been granted to primary insiders. The share options will have a strike price of NOK 15.35 per share, have a five-year term and will vest equally over a four-year vesting period.
Please see further details in attached document.